Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

A Phase II Study About Efficacy and Safety of the Continuous IntraVenous Infusion of Ketamine in Terminally Ill Cancer Patients With Refractory Cancer Pain

To see complete record on, please visit this link

Id: NCT03362073

Organisation Name: Pusan National University Yangsan Hospital

Overal Status: Recruiting

Start Date: June 1, 2018

Last Update: September 28, 2021

Lead Sponsor: Pusan National University Yangsan Hospital

Brief Summary: To establish the role of ketamine in hospitalized terminally ill cancer patients with refractory cancer pain, using continuous intravenous infusion of ketamine

  • Ketamine
  • Refractory Cancer Pain

Total execution time in seconds: 0.39971303939819